Impact Features
Dynamic teams of physicians, researchers, patients, and patient advocates work together in each RDCRN consortium to advance rare diseases research. This page collects feature articles highlighting both the work of the RDCRN consortia and the people behind that work. Choose the consortium acronym at the top of the page to view features articles related to that consortium.
![Phenylketonuria Over Time: What We’re Learning from a Natural History Study](/sites/default/files/styles/news/public/2024-05/RDCRN_Roundup-PHEFREE.jpg?itok=kPnDgI5D)
May 28, 2024
![Keyword co-occurrence visualization map of RDCRN-supported publications 2004–2020.](/sites/default/files/styles/news/public/2024-01/RDCRN_TAIRD_Jan2024.jpg?itok=sCSn81J4)
January 29, 2024
The Rare Diseases Act of 2002 (H.R. 4013) enacted the establishment of the Rare Diseases Clinical Research Network (RDCRN) in 2003.
![Phenylalanine Families and Researchers Exploring Evidence (PHEFREE) logo](/sites/default/files/styles/news/public/2022-11/RDCRN_Blog-PHEFREE.jpg?itok=VeJvkEAS)
November 1, 2022
The Phenylalanine Families and Researchers Exploring Evidence (PHEFREE) Consortium is a group of scientists, clinicians, patients, families…
![Headshot of Stephanie Sacharow, MD](/sites/default/files/styles/news/public/2022-10/RDCRN_Blog-Sacharow.jpg?itok=resZgeLw)
October 25, 2022
Stephanie Sacharow, MD, is a medical geneticist in the Division of Genetics and Genomics at Boston Children’s Hospital and an assistant professor at…